Plasma galactosyl ceramides were investigated in stroke and multiple sclerosis patients. Results showed no significant differences in galactosyl ceramide percentages across controls, multiple sclerosis, and stroke groups, suggesting limited utility as biomarkers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: